Position in NEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$676,629
+$439,367 QoQ
Shares Held
91,190
+533.4% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Bridgewater Associates, LP holds $90,242,179 across 18 Diagnostics & Research names. NEO ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
41,135 | $19,752,615 | |
| 2 | SHC |
Sotera Health Co
|
695,392 | $9,971,921 | |
| 3 | A |
Agilent Technologies, Inc.
|
73,689 | $8,399,072 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
47,119 | $8,035,674 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
14,487 | $7,120,795 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
5,138 | $6,480,045 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
10,314 | $5,795,333 | |
| 8 | NTRA |
Natera, Inc.
|
25,237 | $5,047,147 |
All Filings in NEO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $676,629 | 91,190 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $237,262 | 14,397 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $742,721 | 50,354 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $870,037 | 62,728 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $386,822 | 24,607 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $482,697 | 29,833 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,824,655 | 148,346 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,034,317 | 126,591 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,322,964 | 133,427 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||